172 related articles for article (PubMed ID: 31925967)
1. Hepatitis B Virus Particles Activate Toll-Like Receptor 2 Signaling Initially Upon Infection of Primary Human Hepatocytes.
Zhang Z; Trippler M; Real CI; Werner M; Luo X; Schefczyk S; Kemper T; Anastasiou OE; Ladiges Y; Treckmann J; Paul A; Baba HA; Allweiss L; Dandri M; Gerken G; Wedemeyer H; Schlaak JF; Lu M; Broering R
Hepatology; 2020 Sep; 72(3):829-844. PubMed ID: 31925967
[TBL] [Abstract][Full Text] [Related]
2. Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection.
Luo X; Zhang R; Lu M; Liu S; Baba HA; Gerken G; Wedemeyer H; Broering R
Front Immunol; 2021; 12():684424. PubMed ID: 34113355
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation.
Wang S; Chen Z; Hu C; Qian F; Cheng Y; Wu M; Shi B; Chen J; Hu Y; Yuan Z
J Immunol; 2013 May; 190(10):5142-51. PubMed ID: 23585678
[TBL] [Abstract][Full Text] [Related]
4. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M
J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.
Niu C; Li L; Daffis S; Lucifora J; Bonnin M; Maadadi S; Salas E; Chu R; Ramos H; Livingston CM; Beran RK; Garg AV; Balsitis S; Durantel D; Zoulim F; Delaney WE; Fletcher SP
J Hepatol; 2018 May; 68(5):922-931. PubMed ID: 29247725
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.
Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796
[TBL] [Abstract][Full Text] [Related]
7. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection.
Hösel M; Quasdorff M; Wiegmann K; Webb D; Zedler U; Broxtermann M; Tedjokusumo R; Esser K; Arzberger S; Kirschning CJ; Langenkamp A; Falk C; Büning H; Rose-John S; Protzer U
Hepatology; 2009 Dec; 50(6):1773-82. PubMed ID: 19937696
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver.
Suslov A; Boldanova T; Wang X; Wieland S; Heim MH
Gastroenterology; 2018 May; 154(6):1778-1790. PubMed ID: 29408639
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID).
Watashi K; Liang G; Iwamoto M; Marusawa H; Uchida N; Daito T; Kitamura K; Muramatsu M; Ohashi H; Kiyohara T; Suzuki R; Li J; Tong S; Tanaka Y; Murata K; Aizaki H; Wakita T
J Biol Chem; 2013 Nov; 288(44):31715-27. PubMed ID: 24025329
[TBL] [Abstract][Full Text] [Related]
11. The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection.
Niu C; Livingston CM; Li L; Beran RK; Daffis S; Ramakrishnan D; Burdette D; Peiser L; Salas E; Ramos H; Yu M; Cheng G; Strubin M; Delaney WE; Fletcher SP
PLoS One; 2017; 12(1):e0169648. PubMed ID: 28095508
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis EsxL induces TNF-α secretion through activation of TLR2 dependent MAPK and NF-κB pathways.
Pattanaik KP; Ganguli G; Naik SK; Sonawane A
Mol Immunol; 2021 Feb; 130():133-141. PubMed ID: 33419561
[TBL] [Abstract][Full Text] [Related]
13. Early inhibition of hepatocyte innate responses by hepatitis B virus.
Luangsay S; Gruffaz M; Isorce N; Testoni B; Michelet M; Faure-Dupuy S; Maadadi S; Ait-Goughoulte M; Parent R; Rivoire M; Javanbakht H; Lucifora J; Durantel D; Zoulim F
J Hepatol; 2015 Dec; 63(6):1314-22. PubMed ID: 26216533
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-α and interleukin-1β expression pathway induced by Streptococcus mutans in macrophage cell line RAW 264.7.
Kim JS; Kim KD; Na HS; Jeong SY; Park HR; Kim S; Chung J
Mol Oral Microbiol; 2012 Jun; 27(3):149-59. PubMed ID: 22520385
[TBL] [Abstract][Full Text] [Related]
15. Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients.
Visvanathan K; Lang T; Ryan K; Wilson R; Skinner NA; Thompson AJ; Ahn SH; Weilert F; Abbott W; Gane E; Colledge D; Li K; Locarnini S; Mansell A; Revill PA
J Viral Hepat; 2016 Mar; 23(3):170-9. PubMed ID: 26436722
[TBL] [Abstract][Full Text] [Related]
16. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase.
Hung CC; Chang CT; Tian YC; Wu MS; Yu CC; Pan MJ; Vandewalle A; Yang CW
Nephrol Dial Transplant; 2006 Apr; 21(4):898-910. PubMed ID: 16339163
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of interleukin-17 and tumour necrosis factor-α on inflammatory response in hepatocytes through interleukin-6-dependent and independent pathways.
Beringer A; Thiam N; Molle J; Bartosch B; Miossec P
Clin Exp Immunol; 2018 Aug; 193(2):221-233. PubMed ID: 29676779
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
Zhang E; Lu M
Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115
[TBL] [Abstract][Full Text] [Related]
19. Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line.
Das D; Sengupta I; Sarkar N; Pal A; Saha D; Bandopadhyay M; Das C; Narayan J; Singh SP; Chakrabarti S; Chakravarty R
BMC Infect Dis; 2017 Jan; 17(1):76. PubMed ID: 28088184
[TBL] [Abstract][Full Text] [Related]
20. PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages.
Cabanski M; Steinmüller M; Marsh LM; Surdziel E; Seeger W; Lohmeyer J
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):26-31. PubMed ID: 17690330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
